Alnylam Pharmaceuticals (ALNY) Stock Forecast & Price Target

5 days ago  · Consensus Price Target. According to the 24 analysts' twelve-month price targets for Alnylam Pharmaceuticals, the average price target is $294.50. The highest price target for ALNY is $400.00, while the lowest price target for ALNY is $159.00. The average price target …


Install CouponFollow Chrome Extension   CouponFollow Extension

$294.50
OFF

Alnylam Pharmaceuticals (ALNY) Stock Forecast & Price Target

1 week from now

5 days ago  · Consensus Price Target. According to the 24 analysts' twelve-month price targets for Alnylam Pharmaceuticals, the average price target is $294.50. The highest price target for ALNY is $400.00, while the lowest price target for ALNY is $159.00. The average price target …

marketbeat.com

$178
OFF

What Is The Current Price Target And Forecast For Alnylam ...

1 week from now

Oct 28, 2024  · The current on short-term price targets is based on 8 reports. The forecasts for Alnylam Pharmaceuticals, Inc. (ALNY) range from a low of $178 to a high of $400. The …

zacks.com

$322.83
OFF

Alnylam Pharmaceuticals Stock: A Deep Dive Into Analyst ... - Nasdaq

1 week from now

4 days ago  · In the assessment of 12-month price targets, analysts unveil insights for Alnylam Pharmaceuticals, presenting an average target of $322.83, a high estimate of $400.00, and a …

nasdaq.com

$400.00
OFF

Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock, Analyst Ratings, …

1 week from now

Nov 8, 2024  · While ratings are subjective and will change, the latest Alnylam Pharmaceuticals (ALNY) rating was a reiterated with a price target of $400.00 to $400.00. The current price …

benzinga.com

50%
OFF

ALNY Stock Price Target | Alnylam Pharmaceuticals Analyst Ratings

1 week from now

257 rows  · The average price target is $294.50, with a high forecast of $400.00 and a low forecast of $159.00. The average price target represents a 9.50% upside from the last price of $268.95. …

pricetargets.com

$277.74
OFF

Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Quotes, Forecast …

1 week from now

Alnylam Pharmaceuticals has a consensus price target of $277.74. What is the current price for Alnylam Pharmaceuticals (ALNY)? The stock price for Alnylam Pharmaceuticals (NASDAQ: …

benzinga.com

$294
OFF

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives $294.

1 week from now

1 day ago  · Alnylam Pharmaceuticals Trading Down 8.7 %. Shares of Alnylam Pharmaceuticals stock opened at $235.56 on Friday. The company has a current ratio of 2.75, a quick ratio of …

marketbeat.com

$305.15
OFF

Alnylam Pharmaceuticals Stock Forecast & Predictions: 1Y Price …

1 week from now

On average, Wall Street analysts predict. that Alnylam Pharmaceuticals's share price could reach $305.15 by Nov 4, 2025. The average Alnylam Pharmaceuticals stock price prediction …

wallstreetzen.com

$50
OFF

What Is The Current Price Target And Forecast For Alpha Cognition …

1 week from now

3 days ago  · The forecasts for Alpha Cognition Inc. (ACOG) range from a low of $50 to a high of $50. The average price target represents a increase of $780.28 from the last closing price of …

zacks.com

$90
OFF

Sanmina Price Target Raised To $90 From $80 At Argus - Nasdaq

1 week from now

1 day ago  · Argus raised the firm’s price target on Sanmina (SANM) to $90 from $80 and keeps a Buy rating on the shares after its Q4 earnings beat earlier this month. For the first time since …

nasdaq.com

$8.80
OFF

What Is The Current Price Target And Forecast For CHICAGO ATL …

1 week from now

Average Target Price. $8.80. LT Growth Rate. NA. Industry. Financial - SBIC & Commercial Industry. Industry Rank by ABR. 148 of 252. Current Quarter EPS Est:

zacks.com

100%
OFF

100% Payout And 4% Yield - Why Suncor Is One Of My Best Ideas …

1 week from now

2 hours ago  · One of the most important things to mention is that Suncor achieved its C$8 billion net debt target ahead of schedule. Hence, starting in 4Q24, the company will return 100% of …

seekingalpha.com

$8.00
OFF

Opus Genetics (IRD) Stock Forecast And Price Target 2024

1 week from now

3 days ago  · Consensus Price Target. According to the 1 analysts' twelve-month price targets for Opus Genetics, the average price target is $8.00. The highest price target for IRD is $8.00, …

marketbeat.com

FAQs about Alnylam Pharmaceuticals (ALNY) Stock Forecast & Price Target Coupon?

How far is Alnylam Pharmaceuticals stock from the 52-week high?

According to the current price, Alnylam Pharmaceuticals is 89.66% away from the 52-week high. What are analysts forecasts for Alnylam Pharmaceuticals stock? The 91 analysts offering price forecasts for Alnylam Pharmaceuticals have a median target of 248.15, with a high estimate of 415.00 and a low estimate of 143.00. ...

What is the target price for Alnylam Pharmaceuticals?

The 91 analysts offering price forecasts for Alnylam Pharmaceuticals have a median target of 248.15, with a high estimate of 415.00 and a low estimate of 143.00. The median estimate represents a 109.81 difference from the last price of 272.50. Loading.. ...

Is Alnylam Pharmaceuticals a good investment?

Alnylam Pharmaceuticals has received a consensus rating of Moderate Buy. Based on 15 buy ratings, 6 hold ratings, and no sell ratings, the company's average rating score is 2.71. According to analysts, Alnylam Pharmaceuticals has a forecasted upside of 43.2%, with a consensus price target of $234.76, which is higher than its current price of $163.96. ...

Why did Alnylam Pharmaceuticals stock rise 31%?

Shares of Alnylam Pharmaceuticals (ALNY) skyrocketed over 31% in early trading Monday after the biopharma firm announced strong results from a late-stage study of its RNA interference drug for a rare ... ...

When is Alnylam Pharmaceuticals' next earnings announcement?

Alnylam Pharmaceuticals' next earnings announcement is scheduled for Thursday, November 2nd 2023. The company will be holding an earnings conference call on this day at 8:30 AM Eastern. For more information, view our ALNY earnings forecast. ...

Why is Alnylam stock trading lower?

Friday, Alnylam Pharmaceuticals Inc. ALNY stock is trading lower after the company shared detailed results from the HELIOS-B Phase 3 study of vutrisiran for ATTR amyloidosis with cardiomyopathy (ATTR-... ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension